- Investing Ideas
- Swedish Pharmaceuticals & Biotech Leverage Leaders
Swedish Pharmaceuticals & Biotech Leverage Leaders
Results
3
0 new
3 companies
Camurus
Market Cap: SEK 28.8b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 482.00
7D
1.7%
1Y
-14.5%
BioArctic
Market Cap: SEK 28.5b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 320.80
7D
10.6%
1Y
59.0%
Swedish Orphan Biovitrum
Market Cap: SEK 134.3b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 388.60
7D
1.6%
1Y
37.7%